99 related articles for article (PubMed ID: 10318981)
21. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
22. [Interferon-gamma and neopterin in blood serum of patients with chronic periodontitis after autograft operations].
Bakhtadze MG; Margvelashvili VV; Kamkamidze GK
Georgian Med News; 2006 Mar; (132):30-3. PubMed ID: 16636374
[TBL] [Abstract][Full Text] [Related]
23. Anemia of chronic disease: pathophysiology and laboratory diagnosis.
Thomas C; Thomas L
Lab Hematol; 2005; 11(1):14-23. PubMed ID: 15790548
[TBL] [Abstract][Full Text] [Related]
24. [Function of hepcidin in iron metabolism].
Ikuta K
Rinsho Ketsueki; 2007 Jan; 48(1):36-45. PubMed ID: 17313075
[No Abstract] [Full Text] [Related]
25. Benefits and risks of iron therapy for chronic anaemias.
Weiss G; Gordeuk VR
Eur J Clin Invest; 2005 Dec; 35 Suppl 3():36-45. PubMed ID: 16281957
[TBL] [Abstract][Full Text] [Related]
26. Hepcidin: a direct link between iron metabolism and immunity.
Vyoral D; Petrák J
Int J Biochem Cell Biol; 2005 Sep; 37(9):1768-73. PubMed ID: 16009323
[TBL] [Abstract][Full Text] [Related]
27. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiologic mechanisms of anemia of chronic disease.
Andrews NC
Postgrad Med; 2004 Nov; 116(5 Suppl Anemia):17-22. PubMed ID: 19667680
[TBL] [Abstract][Full Text] [Related]
29. Anemia of chronic disease (anemia of inflammation).
Agarwal N; Prchal JT
Acta Haematol; 2009; 122(2-3):103-8. PubMed ID: 19907147
[TBL] [Abstract][Full Text] [Related]
30. [Interferon-gamma and neopterin in blood serum of patients with chronic periodontitis].
Bakhtadze MG; Margvelashvili VV; Kamkamidze GK
Georgian Med News; 2006 Jan; (130):50-3. PubMed ID: 16510912
[TBL] [Abstract][Full Text] [Related]
31. Nonhematological benefits of iron.
Agarwal R
Am J Nephrol; 2007; 27(6):565-71. PubMed ID: 17804903
[TBL] [Abstract][Full Text] [Related]
32. [Iron, infection and anemia--a classical triad].
Weiss G
Wien Klin Wochenschr; 2002 Jun; 114(10-11):357-67. PubMed ID: 12708088
[TBL] [Abstract][Full Text] [Related]
33. Hepcidin: an important new regulator of iron homeostasis.
Hugman A
Clin Lab Haematol; 2006 Apr; 28(2):75-83. PubMed ID: 16630211
[TBL] [Abstract][Full Text] [Related]
34. Hyporesponsiveness to erythropoietic therapy due to chronic inflammation.
Macdougall IC; Cooper AC
Eur J Clin Invest; 2005 Dec; 35 Suppl 3():32-5. PubMed ID: 16281956
[TBL] [Abstract][Full Text] [Related]
35. Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome.
Besarab A; Hörl WH; Silverberg D
Oncologist; 2009; 14 Suppl 1():22-33. PubMed ID: 19762514
[TBL] [Abstract][Full Text] [Related]
36. Hepcidin--central regulator of iron metabolism.
Atanasiu V; Manolescu B; Stoian I
Eur J Haematol; 2007 Jan; 78(1):1-10. PubMed ID: 17042775
[TBL] [Abstract][Full Text] [Related]
37. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
[TBL] [Abstract][Full Text] [Related]
38. [Pattern of blood levels of erythropoietin and proinflammatory cytokines in patients with anemia of chronic disorders secondary to infection].
Poveda Gómez F; Camacho Siles J; Quevedo Morales E; Fernández Zamorano A; Codoceo Alquinta R; Arnalich Fernández F; Sempere Alcocer M
An Med Interna; 2001 Jun; 18(6):298-304. PubMed ID: 11503575
[TBL] [Abstract][Full Text] [Related]
39. Differential transcriptional responses between the interferon-gamma-induction and iron-limitation models of persistence for Chlamydia pneumoniae.
Timms P; Good D; Wan C; Theodoropoulos C; Mukhopadhyay S; Summersgill J; Mathews S
J Microbiol Immunol Infect; 2009 Feb; 42(1):27-37. PubMed ID: 19424556
[TBL] [Abstract][Full Text] [Related]
40. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
